---
title: "OpusOne pVAD enters first-in-human study"
date: "2025-12-17T11:56:36.000Z"
publishedDate: "17 décembre 2025"
summary: "Enginprime Medical has announced that its percutaneous ventricular assist device (pVAD), OpusOne, has entered its first-in-human clinical study at the Second Affiliated Hospital, School of Medicine, Zhejiang University (SAHZU, Hangzhou, China). This milestone marks the first clinical evaluation of the device&#8217;s safety and performance in patients."
importance: ""
sourceUrl: "https://cardiovascularnews.com/opusone-pvad-enters-first-in-human-study/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-12-17-opusone-pvad-enters-first-in-human-study"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/12/image1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/opusone-pvad-enters-first-in-human-study/"
---

![OpusOne pVAD enters first-in-human study](http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/12/image1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/opusone-pvad-enters-first-in-human-study/*

## L’essentiel

Enginprime Medical has announced that its percutaneous ventricular assist device (pVAD), OpusOne, has entered its first-in-human clinical study at the Second Affiliated Hospital, School of Medicine, Zhejiang University (SAHZU, Hangzhou, China). This milestone marks the first clinical evaluation of the device&#8217;s safety and performance in patients.

## Lien source

https://cardiovascularnews.com/opusone-pvad-enters-first-in-human-study/
